Takeda Pharmaceutical Co., Ltd. (TAK)
16.65
+0.08
(+0.48%)
USD |
NYSE |
May 19, 12:39
Takeda Pharmaceutical Shareholders Equity (Quarterly) : 48.86B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Sanofi | -- |
| Eli Lilly & Co. | 31.20B |
| AstraZeneca PLC | 47.33B |
| Johnson & Johnson | 81.19B |
| Novo Nordisk A/S | 31.31B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 97.13B |
| Total Liabilities (Quarterly) | 48.26B |
| Debt to Equity Ratio | 0.628 |
| Current Ratio | 1.272 |
| Net Debt Paydown Yield | 0.04% |